Top

Journal of Translational Medicine

Published in:

Open Access 01-12-2019 | Research

Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis

Authors: Fouad Mehraban, Arefeh Seyedarabi, Shahin Ahmadian, Vahid Mirzaaghaei, Ali Akbar Moosavi-Movahedi

Published in: Journal of Translational Medicine | Issue 1/2019

Abstract

Background

Diabetes is a chronic disease associated with many problems and high costs. In recent decades, a lot of research has been carried out in order to improve methods of treatment of diabetic patients. One of the currently used complementary therapies for diabetes is ozone therapy or autohemotherapy. The beneficial effects of ozone has been proven in many diseases such as diabetes, but the critical issue is the determination of the safe and effective concentration of ozone reacting with blood and in particular hemoglobin.

Methods

A number of spectroscopic techniques including intrinsic fluorescence, circular dichroism and UV–VIS spectroscopies were used as well as SDS-PAGE, Native-PAGE and dynamic light scattering to analyze the effect of ozonation on hemoglobin of a non-diabetic individual and four diabetic patients in order to find the appropriate concentration(s) of ozone for personalized autohemotherapy.

Results

In this study, we determined the personalized concentration(s) for a safe and effective ozonation of a non-diabetic individual and four diabetic type II patients, based on blood hemoglobin analysis.

Conclusions

A number of techniques were used to determine the personalized ozone concentration(s) for a safe and effective autohemotherapy based on blood hemoglobin analysis. SDS-PAGE and dynamic light scattering were identified as the two main techniques needed for personalizing the ozone concentration(s) for each individual as otherwise hemoglobin in blood can oligomerise and cause serious damage if the inappropriate ozone concentration is used.

Bocci V, Zanardi I, Huijberts MSP, Travagli V. Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes Metab Syndr. 2011;5(1):45–9.PubMedCrossRef

Baynes HW. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J Diabetes Metab. 2015;6(5):1–9.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMedCrossRef

Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical care in diabetes 2017. J Diabetes. 2017;9(4):320–4.PubMedCrossRef

Martinez-Sanchez G, Al-Dalain SM, Menendez S, Re L, Giuliani A, Candelario-Jalil E, et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;523(1):151–61.PubMedCrossRef

Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17(3):189–212.PubMedCrossRef

Elvis AM, Ekta JS. Ozone therapy: a clinical review. J Nat Sci Biol Med. 2011;2(1):66.PubMedPubMedCentralCrossRef

Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29(4):646–82.PubMedCrossRef

Leon OS, Menendez S, Merino N, Castillo R, Sam S, Perez L, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm. 1998;7(4):289–94.PubMedPubMedCentralCrossRef

10.

Calabrese EJ. Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol. 2010;29(4):249–61.PubMedCrossRef

11.

Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med Gas Res. 2011;1(1):29.PubMedPubMedCentralCrossRef

12.

Smith AJ, Oertle J, Warren D, Prato D. Ozone therapy: a critical physiological and diverse clinical evaluation with regard to immune modulation, anti-infectious properties, anti-cancer potential, and impact on anti-oxidant enzymes. Open J Mol Integr Physiol. 2015;5(03):37.CrossRef

13.

Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G. Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflamm. 2007. https://doi.org/10.1155/2007/26785.PubMedPubMedCentralCrossRef

14.

Candelario-Jalil E, MohammedAl-Dalain S, Fernandez OS, Menendez S, Perez-Davison G, Merino N, et al. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol. 2001;21(4):297–301.PubMedCrossRef

15.

Peralta C, Leon OS, Xaus C, Prats N, Jalil EC, Planell ES, et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radical Res. 1999;31(3):191–6.CrossRef

16.

Peralta C, Xaus C, Bartrons R, Leon OS, Gelpi E, Rosell-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radical Res. 2000;33(5):595–605.CrossRef

17.

Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol Appl Pharmacol. 2006;216(3):493–504.PubMedCrossRef

18.

Bocci V. The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007;64(1):44–9.PubMedCrossRef

19.

Viebahn-Hansler R, Leon Fernandez OS, Fahmy Z. Ozone in medicine: the low-dose ozone concept-guidelines and treatment strategies. Ozone Sci Eng. 2012;34(6):408–24.CrossRef

20.

Bocci V, Zanardi I, Travagli V. Ozone: a new therapeutic agent in vascular diseases. Am J Cardiovasc Drugs. 2011;11(2):73–82.PubMedCrossRef

21.

Karnaukhova E, Rutardottir S, Rajabi M, Rosenlof LW, Alayash AI, Akerstrom B. Characterization of heme binding to recombinant a1-microglobulin. Front Physiol. 2014;5:465.PubMedPubMedCentralCrossRef

22.

Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4(2):89.PubMedPubMedCentral

23.

Rahbani-Nobar ME, Rahimi-Pour A, Rahbani-Nobar M, Adi-Beig F, Mirhashemi SM. Total antioxidant capacity, superoxide dismutase and glutathione peroxidase in diabetic patients. Med J Islam Acad Sci. 1999;12(4):109–14.

24.

Serafini M, Villano D, Spera G, Pellegrini N. Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr Cancer. 2006;56(2):232–40.PubMedCrossRef

25.

Travagli V, Zanardi I, Bernini P, Nepi S, Tenori L, Bocci V. Effects of ozone blood treatment on the metabolite profile of human blood. Int J Toxicol. 2010;29(2):165–74.PubMedCrossRef

26.

Mehraban F, Seyedarabi A, Seraj Z, Ahmadian S, Poursasan N, Rayati S, et al. Molecular insights into the effect of ozone on human hemoglobin in autohemotherapy: highlighting the importance of the presence of blood antioxidants during ozonation. Int J Biol Macromol. 2018;119:1276–85.PubMedCrossRef

27.

Travagli V, Zanardi I, Silvietti A, Bocci V. A physicochemical investigation on the effects of ozone on blood. Int J Biol Macromol. 2007;41(5):504–11.PubMedCrossRef

28.

Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med. 2011;9(1):66.PubMedPubMedCentralCrossRef

29.

Bocci V. Ozone A new medical drug. The Netherlands: Springer; 2005.

30.

Trachootham D, Lu W, Ogasawara MA, Valle NRD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal. 2008;10(8):1343–74.PubMedPubMedCentralCrossRef

31.

Munoz G, De Juan A. pH-and time-dependent hemoglobin transitions: a case study for process modelling. Anal Chim Acta. 2007;595(1):198–208.PubMedCrossRef

32.

Basu A, Kumar GS. Interaction of toxic azo dyes with heme protein: biophysical insights into the binding aspect of the food additive amaranth with human hemoglobin. J Hazard Mater. 2015;289:204–9.PubMedCrossRef

33.

Li D, Zhang T, Ji B. Influences of pH, urea and metal ions on the interaction of sinomenine with Lysozyme by steady state fluorescence spectroscopy. Spectrochim Acta Part A Mol Biomol Spectrosc. 2014;130:440–6.CrossRef

34.

Li R, Nagai Y, Nagai M. Changes of tyrosine and tryptophan residues in human hemoglobin by oxygen binding: near-and far-UV circular dichroism of isolated chains and recombined hemoglobin. J Inorg Biochem. 2000;82(1):93–101.PubMedCrossRef

35.

Cataldo F, Gentilini L. On the action of ozone on whole bovine blood. Polym Degrad Stab. 2005;89(3):527–33.CrossRef

36.

Sharma VK, Graham NJD. Oxidation of amino acids, peptides and proteins by ozone: a review. Ozone Sci Eng. 2010;32(2):81–90.CrossRef

37.

Stryer L. Biochemistry, 1995. New York: H Freeman & Co; 1995.

38.

Carvalho FAO, Carvalho JWP, Santiago PS, Tabak M. Further characterization of the subunits of the giant extracellular hemoglobin of Glossoscolex paulistus (HbGp) by SDS-PAGE electrophoresis and MALDI-TOF-MS. Process Biochem. 2011;46(11):2144–51.CrossRef

39.

Nagababu E, Rifkind JM. Heme degradation by reactive oxygen species. Antioxid Redox Signal. 2004;6(6):967–78.PubMed

40.

Kampf CJ, Liu F, Reinmuth-Selzle K, Berkemeier T, Meusel H, Shiraiwa M, et al. Protein cross-linking and oligomerization through dityrosine formation upon exposure to ozone. Environ Sci Technol. 2015;49(18):10859–66.PubMedCrossRef

Title: Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis
Authors: Fouad Mehraban
Arefeh Seyedarabi
Shahin Ahmadian
Vahid Mirzaaghaei
Ali Akbar Moosavi-Movahedi
Publication date: 01-12-2019
Publisher: BioMed Central
Published in: Journal of Translational Medicine / Issue 1/2019
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-019-1973-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Development of a novel ssDNA aptamer targeting neutrophil gelatinase-associated lipocalin and its application in clinical trials

ARL3 is downregulated and acts as a prognostic biomarker in glioma

Overexpression of circulating MiR-30b-5p identifies advanced breast cancer

Comparison and characterization of enriched mesenchymal stem cells obtained by the repeated filtration of autologous bone marrow through porous biomaterials

Proteomic profiling of plasma biomarkers in acute ischemic stroke due to large vessel occlusion

New paradigm for stage III melanoma: from surgery to adjuvant treatment

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page